Reviva Pharmaceuticals, Inc. (RVPH) - Kapitalizatsiyaning foydaga nisbati

Reviva Pharmaceuticals Holdings Inc. (RVPH) brendining ramzi va logotipi

Reviva Pharmaceuticals (RVPH) mavjudligi shizofreniya dori vositalarini sinovdan o'tkazish natijalariga kritik bog'liqlik va naqd pullarning tez sur'atlarda sarflanishi tufayli xavf ostida qolgan. Biroq, psixiatrik kasalliklarni davolashdagi noyob patentlar kelajakdagi pul oqimlarini yaratish uchun asos yaratadi. -0.20 metrikasi aks etgan ushbu narxlar grafigi savdolarning yo'qligini ko'rsatmoqda, chunki yakuniy bosqichdagi sinovlar xarajatlari tadqiqot ko'lamiga mutanosib ravishda ortib bormoqda.

RVPH - Reviva Pharmaceuticals Holdings, Inc. P/E multiplikatori 04.07.2022 - 16.05.2026 oraligʻida

Reviva Pharmaceuticals, Inc. (RVPH) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya kursi va ekspertlarning narx prognozi:
Narxlar dinamikasi grafigi Reviva Pharmaceuticals Holdings, Inc.|RVPH - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Reviva Pharmaceuticals, Inc.|RVPH - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya uchun sof aktivlar Reviva Pharmaceuticals|RVPH - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi revivapharma.com|RVPH - Kompaniyaning yakuniy aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Reviva Pharmaceuticals|RVPH - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Reviva Pharmaceuticals Holdings, Inc.|RVPH - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Reviva Pharmaceuticals Holdings|RVPH - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Reviva Pharmaceuticals|Oraliq qoplash koeffitsiyenti revivapharma.com
- foyda va bozor koeffitsiyentlari statistikasi:
RVPH - Sof foyda|Prognoz qilingan kelajakdagi foyda Reviva Pharmaceuticals|RVPH - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Reviva Pharmaceuticals, Inc.|RVPH - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Reviva Pharmaceuticals Holdings Inc.|RVPH - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Reviva Pharmaceuticals|RVPH - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi revivapharma.com|RVPH - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Reviva Pharmaceuticals
- kompaniyaning sotuvlari va tushumi statistikasi:
RVPH - Kompaniya savdosi|Prognoz qilingan sotish hajmi Reviva Pharmaceuticals Holdings|RVPH - Kapitalizatsiyaning daromadga nisbati|Narxning kutilayotgan daromadga nisbati Reviva Pharmaceuticals Holdings Inc.|RVPH - Yillik sotuv o'sishi (TTM)
Kompaniyaning umumiy tahlili:Reviva Pharmaceuticals Holdings Inc. - RVPH
Reviva Pharmaceuticals Holdings brendining mahsuloti

Himoyalangan AQSh yurisdiksiyasi doirasida neyropsixiatrik dori vositalarini ishlab chiqish Reviva Pharmaceuticals (RVPH) uchun tartibga soluvchi o'zgarishlar xavfini minimallashtiradi va uning intellektual aktivlari barqarorligini ta'minlaydi. Bozor kapitalizatsiyasining sof foydaga nisbati bo'yicha kunlik hisob-kitoblar bozor shovqinlarini yumshatishga va adolatli narx oralig'ini aniqlashga yordam beradi, bu esa investorlarga P/E ko'rsatkichi tahlili orqali eyforiya cho'qqilari paytida ortiqcha to'lov qilishdan qochishda ko'maklashadi.

Raqobatdosh kompaniyalar tahlili

Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalizatsiyaning sof foydaga nisbati|anavex.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell, Inc.)|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon Biosciences Inc.) - P/E multiplikatori|omeros.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurogene (NGNE)|Biznesning o‘zini qoplash muddati AC Immune SA|P/E multiplikatori VYGR (voyagertherapeutics.com)|P/E multiplikatori Neumora NMRA|Scilex Holding - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Narxning foydaga nisbati|cogrx.com (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Assertio Therapeutics (ASRT)|Biznesning o‘zini qoplash muddati Coya|Vistagen - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OVID|Acumen Pharmaceuticals Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CervoMed Inc|ATHE: P/E multiplikatori|Narx-foyda koeffitsiyenti Clene Nanomedicine|Narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalizatsiyaning foydaga nisbati|gracetx.com - Narx-foyda koeffitsiyenti|AIFF: Narx-foyda multiplikatori|Klotho Neurosciences - P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narx-foyda multiplikatori|MTVA (MetaVia Inc.) - Narx-foyda koeffitsiyenti|NeurAxis Inc. (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical|Passage Bio, Inc. - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti NEUP (Neuphoria)|NERV - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ATHA (athira.com)|P/E multiplikatori Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - P/E multiplikatori|CYCN - P/E multiplikatori|PTIX (Protagenic Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Pasithea (KTTA)|Narxning foydaga nisbati Cortigent|Kapitalizatsiyaning foydaga nisbati Avenue Therapeutics Inc. ATXI|Narxning foydaga nisbati brainstorm-cell.com (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics, Inc CARA|P/E multiplikatori CHRO (chromocell.com)|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori